Abstract
Lenalidomide in Combination with CHOP in Patients with Angioimmunoblastic T-Cell Lymphoma (AITL): Final Analysis of Clinical and Molecular Data of a Phase 2 Lysa Study
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have